Status:
COMPLETED
The Effect of Dionegest Use on the Frequency of Fibromyalgia in Endometriosis
Lead Sponsor:
Gaziosmanpasa Research and Education Hospital
Conditions:
Fibromyalgia
Endometriosis Ovary
Eligibility:
FEMALE
18-40 years
Brief Summary
Endometriosis usually occurs during the reproductive period of women and poses a significant burden on quality of life and social costs. The estimated prevalence in premenopausal women is 10% in clini...
Detailed Description
Although little is known about the causes of endometriosis, it is reported that women with endometriosis have a high rate of comorbidity with other chronic pain syndromes associated with peripheral an...
Eligibility Criteria
Inclusion
- 18 - 40 years old
- Nulliparity
- Women diagnosed with endometrioma (unilateral, ≤ 4cm) by physical examination and vaginal/transabdominal ultrasonography
Exclusion
- Pelvic mass that cannot be differentially diagnosed by physical examination and imaging techniques
- Endometrioma cases with surgical treatment indication
- Any concurrent major psychiatric disorder
- Any medical condition that may interfere with sensory perception (diabetes, neurological disorder, etc.)
- Presence of any other concomitant painful condition other than fibromyalgia and endometriosis
- Currently using any hormonal therapy
- History and/or presence of malignancy
- Pregnancy
- Menopause or premature ovarian failure
Key Trial Info
Start Date :
June 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2022
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT05272930
Start Date
June 30 2021
End Date
April 30 2022
Last Update
February 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gaziosmanpasa Training and Research Hospital
Istanbul, Turkey (Türkiye)